US Panel of Experts Supports Pfizer Booster Dose in Minors – Tech Viral Tips

public health advisor we he said that Vaccinated teens should get a COVID-19 booster shot from Pfizer BioNTech, An important step in efforts to increase vaccines and keep schools open.

Panel of external experts convened by Centers for Disease Control and Prevention (CDC), voted 13 to 1 to recommend a booster vaccine for people 12 to 17 years She received your second dose at least five months ago, CDC DirectorRochelle Valensky made this supporting the recommendation Officer,

Agency Advisory Committee on Immunization Practices Found after emergency clearance of third encouragement by the Food and Drug Administration (FDA) on Monday.

are gaining importance as a highly permeable version of immunizations and boosters omicron, quickly overtaken delta To become the dominant tension in the United States.

While Omicron appears to cause less severe disease, Large number of patients burdened hospitals and health workers,

“It is vital that we protect our children and adolescents from the complications of COVID-19 infection and serious illness,” Valensky said in a statement late Wednesday. “I encourage all parents to keep their children up to date with the CDC’s COVID-19 vaccine recommendations.”

Vaccines’ ‘fading’ effect

Research indicates that the effects of Pfizer-BioNTech’s initial two-dose regimen are getting worse than those of Omicron, and that Immunity to COVID can be restored with boosters,

Parents are keen to give children a shield against illness, especially when students and teachers return to school after the holidays.

This is the first time the committee has considered a third vaccination for adolescents. 12 to 15 years, Boosters are available for 16-17-year-olds through December 9, but the panel’s recommendation reinforces calls for additional shots in that group.

“It’s another tool in our toolbox and if it’s a hammer, we should hit that nail hard,” he said. Oliver Brooks, a panel member who is also the medical director of Watts Healthcare Corp. in Los Angeles.

In addition to preventing coronavirus hospitalizations and deaths, two doses of the Pfizer-BioNTech vaccine had a 91 percent efficacy rate against a serious condition called multisystem inflammatory syndrome in children, CDC epidemiological intelligence officer Sarah Oliver said in a presentation. The finding was based on a case–control study involving more than 100 MIS-C patients and 181 hospitalized people aged 12 to 18 years.

Of the 8.6 million children ages 12 to 15 in the United States who are fully vaccinated, approximately 5 million received the vaccines more than five months ago and would be eligible for a booster dose immediately.

Is a booster dose necessary in minors?

During the meeting, experts discussed safety concerns with vaccines, including myocarditis, a heart condition seen primarily in young men who have received messenger RNA vaccines.

risk of myocarditis The age of 16 to 17 seems to be at its peak, she said Peter MarxThe director of the FDA’s Center for Biological Research and Evaluation said in a press call Monday.

After nearly 19 million doses of Pfizer injections were given to young teens in late December, there were 265 Reports of MyocarditisAccording to CDC data presented at the meeting.

Most cases occurred after the second dose of the vaccine and mainly in men. While most patients recovered from their symptoms, 8 percent are still being monitored.

According to a presentation by CDC epidemiologists, of the 47,000 Americans ages 16-17 and about 93,000 ages 18-24 who have received boosters, there have been only 13 initial reports of myocarditis after the injection. john soo,

While the data seems reassuring, It may be premature to determine whether a booster is safe in younger age groups.Panel member Sarah Long said at the meeting.

Long, a professor of pediatrics at Drexel University School of Medicine in Philadelphia, said, “I can see you concluding for waiting parents that there are no worrisome signs, but I think it’s too early to tell.” “

The commission debated how strong the recommendation should be, whether to say that juveniles “can” or “should” receive reinforcements. as a last resort, Most of the members decided to come strongly in favor of booster doses throughout the age group.

“This is the tool we need to use and help our children overcome this pandemic,” he said. Katherine Poehling, a pediatrician and epidemiologist at Wake Forest School of Medicine in Winston-Salem, North Carolina.